Zaleplon. Sedative/hypnotic

Drugs of the Future

Volumn 21, Issue 1, 1996, Pages 37-39

  Mealy, N ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; HYPNOTIC AGENT; SEDATIVE AGENT; TRIAZOLAM; VALPROIC ACID; ZALEPLON;

ANTICONVULSANT ACTIVITY; DOG; DROWSINESS; DRUG METABOLISM; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; HYPNOSIS; MONKEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SHORT SURVEY; SLEEP PATTERN; TRANQUILIZING ACTIVITY;

EID: 3643087016     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.01.335499     Document Type: Article

References (15)

1. Dusza, J.P., Tomcufcik, A.S., Albright, J.D. (American Cyanamid Co.). [7-(3-Disubstd. amino)phenyl]pyrazolo[1,5-a]pyrimidines. EP 208846, JP 86260083, JP 95084468, US 4626538.
2. Noguchi, H., Kitazumi, K., Sasaki, M., Suzuki, H., Shiba, T., Nishiki, K., Inomata, N. Hypnotic effect of CL284,846, a new non-benzodiazepine. Jpn J Pharmacol 1995, 67(Suppl. 1): Abst P1-266.
3. Day, I.P., Clody, D.E., Monaghan, M.M., Abel, M.S., Dusza, J.P., Beer, B. Pharmacology of CL 284,846, a non-benzodiazepine sedative with reduced amnestic liability. Soc Neurosci Abst 1992, 18(Part 1). Abst 303 4.
4. Vanover, K.E., Barrett, J.E. Evaluation of the discriminative stimulus effects of the novel putative sedative-hypnotic CL 284,846. Soc Neurosci Abst 1993, 19(Part 2): Abst 569.15.
5. Gaudreault, J., Varin, F., Pollack, G.M. Pharmacokinetics (PK) and pharmacodynamics (PD) of CL 284,846 (CL) in rats. Pharm Res 1993, 10(10, Suppl.): Abst PPDM 8349.
6. Wirth, M., Chaudhary, I., Cosulich, D., Nicolau, G. In vitro metabolism of CL284,846, a novel non-benzodiazepine sedative/hypnotic, in human and monkey liver preparations. Pharm Res 1993, 10(10, Suppl.): Abst PPDM 8130.
7. Chaudhary, I., DeMaio, W., Kantrowitz, J. Species comparison of in vitro and in vivo metabolism of CL 284,846, a non-benzodiazepine sedative/hypnotic agent. Pharm Res 1994, 11(10, Suppl.): Abst PPDM 8236.
8. Chaudhary, I., DeMaio, W., Kelly, R.G., Morton, G., Cosulich, D., Nicolau, G. In vitro and in vivo metabolism of CL284,846, a novel non-benzodiazepine sedative/hypnotic in humans. Pharm Res 1993, 10(10, Suppl.): Abst PPDM 8129.
9. Woolcock, I.M., Doepner, D., Milisci, M., Amorusi, P., Wolford, S., Tham, P., Halperin-Walega, E. Pharmacokinetics of CL 284,846 after multiple oral doses to dogs and rats. Pharmacologist 1991, 33(3): Abst 209.
10. Vanover, K.E., Mangano, R.M., Barrett, J.E. CL 284,846, a novel sedative-hypnotic: Evaluation of its metabolites for pharmacological activity in vitro and in vivo. Drug Develop Res 1994, 33: 39-45.
11. Beer, B., Ieni, J.R., Wu, W.-H., Clody, D., Amorusi, P., Rose, J., Mant, T., Gaudreault, J., Cato, A., Stern, W. A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic. J Clin Pharmacol 1994, 34(4): 335-44.
12. Uchiumi, M., Sugiyama, T., Suzuki, M., Murasaki, M. Phase I study of LJC 10,846 (L-846), a novel benzodiazepine receptor-related hypnotic - Comparative double-blind study with placebo. Jpn J Neuropsychopharmacol 1995, 17(3): 185-202.
13. American Home Products Corp. Analyst Presentation (April 10, New York) 1995.
14. American Home Products Corporation holds analyst meeting. American Home Products Corp. Press Release 1995, April 10.
15. Sanger, D.J. Behavioural effects of novel benzodiazepine (omega) receptor agonists and partial agonists: Increases in punished responding and antagonism of the pentylenetetrazole cue. Behav Pharmacol 1995, 6: 116-26.